Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03417479 · ClinicalTrials.gov registry record
Gabapentin Premedication for ACL Reconstruction: RCT
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Completed
- Registry status
- 57
- Enrollment target
NCT03417479 is a clinical trial that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 57 participants.
The verdict
NCT03417479 has completed, sponsored by Children's Healthcare of Atlanta.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
This double blind randomized control trial will enroll 100 participants ages 12-18 years, undergoing ACL repair. Participants receive gabapentin or placebo preoperatively. Outcome measurements of self-reported pain score using scale of 1 to 10 with 10 being the worse obtained from the EMR and participants interviews with a phone nurse for five days postoperatively to determine severity of pain as well as use of opioids.
Interventions
- OTHER Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2015-10-09 |
| Est. Completion | 2018-10-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03417479
The ClinicalTrials.gov registry entry for NCT03417479 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gabapentin is the first listed.
NCT03417479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03417479 about?
NCT03417479 is a clinical study titled "Gabapentin Premedication for ACL Reconstruction: RCT". This double blind randomized control trial will enroll 100 participants ages 12-18 years, undergoing ACL repair. Participants receive gabapentin or placebo preoperatively. Outcome measurements of self-reported pain score using scale of 1 to 10 with 10 being the worse obtained from the EMR and partic...
What is the current status of trial NCT03417479?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2015-10-09. Estimated completion is 2018-10-23.
What interventions are being tested in trial NCT03417479?
The interventions under investigation include: Gabapentin (OTHER).
Who is sponsoring clinical trial NCT03417479?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.